BIOSYNTHETIC TECHNOLOGIES, LLC — Form D/A
BIOSYNTHETIC TECHNOLOGIES, LLC of IRVINE, CA, a company, filed a Form D amendment with the SEC on 2017-02-07. The offering totals $28.0M, of which $16.5M was reported sold. Industry: Manufacturing.
Offering
- Filed: 2017-02-07
- Form: D/A
- Accession: 0001577689-17-000005
- Industry: Manufacturing
- Exemptions: 06b
- Total offering: $28.0M
- Amount sold: $16.5M
- Remaining: $11.5M
- Investors: 5
- Date of first sale: 2016-12-27
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-278003
Issuer
- Name: BIOSYNTHETIC TECHNOLOGIES, LLC
- CIK: 0001577689
- Entity type: Limited Liability Company
- Jurisdiction: MONTANA
- Incorporated: 2010
- Address: 2 PARK PLAZA, IRVINE, CA, 92614
- Phone: 949-390-5910
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| Allen Barbieri | Director | Irvine, CA |
| Steve Bierschenk | Director | St. Louis, MO |
| John Hopkins | Director | Carolina, PR |
| Gerald Kohlenberger | Director | Irvine, CA |
| Bernhard Mohr | Director | Cambridge, MA |
| Meghan Sharp | Director | San Francisco, CA |
| Kent Wasson | Director | Irvine, CA |
| Allen Barbieri | Executive Officer | Irvine, CA |
| Steven Bierschenk | Director | St. Louis, MO |
Other filings by this issuer (4)
More